In patients with poorly controlled T2D, 6 months of treatment with liraglutide 1.2 mg/day significantly reduced liver fat content as evaluated by 1 H-magnetic resonance spectroscopy, an effect mainly driven by bodyweight loss (65)
The active ingredient in Ozempic, semaglutide, is a GLP-1 receptor antagonist
Starting at 2mg reduces nausea rates significantly compared to starting at 4mg, but it also delays the onset of meaningful appetite suppression by approximately 4 weeks
The problem is large portions of highly refined carbohydrate without enough protein or fiber
When considering a mots c retatrutide stack in a research context, several factors would need careful consideration: Independent Dosing and Timing: Researchers would likely start with established research protocols for each peptide individually before considering any modifications for a stack
New or worsening depression or anxiety that goes beyond simple tiredness